Beta-lactamase inhibitors
US10214547B2 · kind B2 · utility
8Cited by
16References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 18, 2017 |
| Grant date | Feb 26, 2019 |
| Priority date | — |
| Expiry date | Oct 18, 2037 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Described herein are compounds and compositions that modulate the activity of beta-lactamases. In some embodiments, the compounds described herein inhibit beta-lactamase. In certain embodiments, the compounds described herein are useful in the treatment of bacterial infections.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.